AllerVie Health, a Dallas-based provider of allergy and immunology services in the United States, announced several key management hires and corporate promotions as part of its goal to optimize operations, build out and diversify clinical service offerings, and drive organic growth across the organization.
The company said the hires and promotions are an outgrowth of an exponential year of expansion for AllerVie, which grew to nearly 600 employees and successfully acquired seven practices in 2022.
Since its formation in December 2020, AllerVie has acquired 23 allergy practices across the country.
“AllerVie Health is excited to be at the forefront of allergy and asthma healthcare and innovation. Not only are we serving more patients than ever, but we’re continuing to advance excellence in clinical research,” CEO Chris Roussos said in a statement. “Our new additions to management and our internal promotions represent our ability as a company to attract and advance talented healthcare professionals as we seek to take our operations to new levels as a patient and service-driven organization.”
Veronica Elliott joins as AllerVie’s national director of compliance. Elliot has over 15 years of compliance, risk, and regulatory experience. She is a licensed RN with a master’s in nursing administration and will support AllerVie’s companywide compliance initiatives.
Christopher Meyer joins AllerVie as senior director of operations. Meyer has two decades of healthcare experience. He began his career as a clinician in Denver, Colo. as a respiratory therapist, where he later became the director of cardiopulmonary. Meyer transitioned into senior leadership roles responsible for delivering operational and strategic initiatives. He will assume leadership of practice locations in Alabama, Texas, Colorado, Ohio, Indiana, Connecticut, and Georgia.
William Meyers has been promoted to senior associate of corporate development. In this role, Meyers will continue to support AllerVie with acquisition and expansion-related initiatives, integration efforts, legal matters, and more. He will continue to be a primary point of contact for AllerVie’s partners.
Vikki Spencer has been promoted to associate director of operations and clinical operations support. Spencer brings over 20 years of allergy experience and a proven track record to the AllerVie operations team in her new role. Formerly a practice administrator for AllerVie, Spencer will assume oversight of four practice locations in Connecticut and five in Georgia.
Dr. Weily Soong transitioned from chief medical officer to chief research innovation officer for AllerVie Clinical Research on April 1. In this role, he leads the company’s efforts to drive innovation by advancing new therapies for asthma, allergies, and other related immunological conditions. In addition to this, he will remain a treating part-time physician with AllerVie Health, where he formerly practiced for 17 years in the Birmingham, Ala., area. Soong completed his Internal Medicine residency at Yale University in New Haven, Conn., and remained at Yale for his Allergy and Clinical Immunology Fellowship training.
In addition to these new hires and restructuring changes, AllerVie said it will be transitioning the role of chief medical officer to an advisory board guided by representatives and experts across AllerVie.
AllerVie Health, a national network of board-certified allergists and immunologists, served more than 100,000 patients in 2022, the company said.
It serves patients across 12 states in 76 clinic locations.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.